Name:	O
___.	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
M	O
Service:	O
MEDICINE	O
Allergies:	O
No	O
Known	O
Allergies	O
/	O
Adverse	O
Drug	O
Reactions	O
Attending:	O
___.	O
Chief	O
Complaint:	O
Mr.	O
___	O
is	O
a	O
___	O
with	O
hx	O
of	O
HTN/HLP	O
recently	O
dx	O
with	O
DLBCL	O
sp	O
C1	O
DA-EPOCH-R	O
c/b	O
neutropenic	O
fever.	O
He	O
is	O
here	O
today	O
for	O
planned	O
admission	O
for	O
C2	O
EPOCH	O
and	O
port	O
exchange.	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
port	O
placed	O
History	O
of	O
Present	O
Illness:	O
Mr	O
___	O
presented	O
on	O
___	O
with	O
2	O
days	O
of	O
left	O
flank	O
pain.	O
CT	O
showed	O
large	O
L	O
renal	O
mass	O
and	O
multiple	O
surrounding,	O
necrotic	O
nodes	O
c/f	O
malignancy.	O
CT	O
chest	O
was	O
clear.	O
He	O
underwent	O
___	O
biopsy	O
of	O
tumor	O
mass	O
___.	O
Pathology	O
returned	O
positive	O
for	O
DLBCL	O
and	O
he	O
was	O
admitted	O
to	O
___	O
from	O
___	O
-	O
___	O
to	O
initiate	O
treatment.	O
-	O
___:	O
C1	O
DA-EPOCH	O
-	O
___:	O
C1	O
Rituximab	O
On	O
___	O
he	O
presented	O
to	O
the	O
ED	O
and	O
was	O
admitted	O
with	O
neutropenic	O
fever.	O
He	O
was	O
started	O
on	O
vancomycin	O
and	O
cefepime	O
that	O
was	O
narrowed	O
on	O
___	O
to	O
levofloxacin.	O
Infectious	O
workup	O
including	O
blood/urine	O
culture	O
and	O
chest	O
x-ray,	O
influenza	O
swab	O
was	O
negative.	O
Respiratory	O
Viral	O
PCR	O
Panel	O
was	O
positive	O
for	O
parainfluenza	O
virus.	O
He	O
will	O
complete	O
a	O
10-day	O
course	O
of	O
levofloxacin	O
which	O
will	O
be	O
complete	O
on	O
___	O
d/t	O
concern	O
for	O
superimposed	O
bacterial	O
pneumonia.	B-Lower_respiratory_tract_infection
His	O
neupogen	O
was	O
held	O
prior	O
to	O
discharge.	O
He	O
had	O
a	O
follow-up	O
chest	O
x-ray	O
prior	O
to	O
discharge	O
that	O
showed	O
no	O
evidence	O
of	O
pneumonia.	B-Lower_respiratory_tract_infection
Past	O
Medical	O
History:	O
HTN	O
HLD	O
Raynaud's	O
Anxiety	O
GERD	O
Dyspnea	O
on	O
exertion	O
Chronic	O
cough	O
BPH	O
Social	O
History:	O
___	O
Family	O
History:	O
His	O
mother	O
has	O
a	O
history	O
of	O
breast	O
cancer	O
and	O
stroke,	O
father	O
has	O
a	O
history	O
of	O
melanoma	O
and	O
alcohol	O
use.	O
There	O
is	O
no	O
known	O
family	O
history	O
of	O
urologic	O
malignancy.	O
Physical	O
Exam:	O
ADMISSION	O
PHYSICAL	O
___	O
___	O
Temp:	O
98.1	O
PO	O
BP:	O
138/81	O
HR:	O
64	O
RR:	O
16	O
O2	O
sat:	O
98%	O
O2	O
delivery:	O
RA	O
GENERAL:	O
Well-appearing,	O
no	O
acute	O
distress.	O
NECK:	O
Soft	O
and	O
supple.	O
PSYCH:	O
A&O	B-Delirium
x3,	B-Delirium
full	O
affect.	O
CARDIAC:	O
Regular	O
rate	O
and	O
rhythm.	O
No	O
murmurs,	O
gallops,	O
or	O
rubs.	O
CHEST:	O
Clear	O
to	O
auscultation	O
and	O
percussion	O
bilaterally.	O
No	O
wheezes,	O
rales,	O
or	O
rhonchi.	O
ABDOMEN:	O
Soft,	O
nontender,	O
nondistended,	O
no	O
hepatosplenomegaly	O
palpated	O
or	O
percussed.	O
Positive	O
bowel	O
sounds.	O
BACK:	O
No	O
spinal	O
or	O
CVA	O
tenderness.	O
SKIN:	O
No	O
rashes	O
notes	O
EXTREMITIES:	O
No	O
___	O
edema.	O
NEUROLOGIC:	O
Normal	O
gait	O
and	O
stance,	O
rises	O
easily	O
from	O
chair.	O
DISCHARGE	O
PHYSICAL	O
Temp:	O
97.7	O
PO.	O
BP143	O
/	O
74HR92R18	O
O296	O
GENERAL:	O
Well-appearing,	O
no	O
acute	O
distress.	O
NECK:	O
Soft	O
and	O
supple.	O
PSYCH:	O
A&O	B-Delirium
x3,	B-Delirium
full	O
affect.	O
CARDIAC:	O
Regular	O
rate	O
and	O
rhythm.	O
No	O
murmurs,	O
gallops,	O
or	O
rubs.	O
CHEST:	O
Clear	O
to	O
auscultation	O
and	O
percussion	O
bilaterally.	O
No	O
wheezes,	O
rales,	O
or	O
rhonchi.	O
ABDOMEN:	O
Soft,	O
nontender,	O
nondistended,	O
no	O
hepatosplenomegaly	O
palpated	O
or	O
percussed.	O
Positive	O
bowel	O
sounds.	O
BACK:	O
No	O
spinal	O
or	O
CVA	O
tenderness.	O
SKIN:	O
No	O
rashes	O
notes	O
EXTREMITIES:	O
No	O
___	O
edema.	O
NEUROLOGIC:	O
Normal	O
gait	O
and	O
stance,	O
rises	O
easily	O
from	O
chair.	O
ACCESS:	O
port	O
in	O
place	O
on	O
chest	O
wall	O
with	O
minimal	O
swelling.	O
Pertinent	O
Results:	O
___	O
12:00AM	O
BLOOD	O
WBC-3.9*	O
RBC-3.73*	O
Hgb-10.1*	O
Hct-31.3*	O
MCV-84	O
MCH-27.1	O
MCHC-32.3	O
RDW-14.1	O
RDWSD-41.2	O
Plt	O
___	O
___	O
12:00AM	O
BLOOD	O
Neuts-90.7*	O
Lymphs-2.6*	O
Monos-5.9	O
Eos-0.0*	O
Baso-0.0	O
Im	O
___	O
AbsNeut-3.51	O
AbsLymp-0.10*	O
AbsMono-0.23	O
AbsEos-0.00*	O
AbsBaso-0.00*	O
___	O
12:00AM	O
BLOOD	O
Glucose-133*	O
UreaN-19	O
Creat-0.7	O
Na-145	O
K-4.2	O
Cl-107	O
HCO3-25	O
AnGap-13	O
___	O
12:00AM	O
BLOOD	O
ALT-41*	O
AST-28	O
LD(LDH)-204	O
AlkPhos-70	O
TotBili-0.2	O
___	O
12:00AM	O
BLOOD	O
Albumin-3.3*	O
Calcium-8.2*	O
Phos-3.7	O
Mg-2.0	O
UricAcd-4.2	O
Brief	O
Hospital	O
Course:	O
Mr.	O
___	O
is	O
a	O
___	O
with	O
hx	O
of	O
HTN/HLP	O
recently	O
dx	O
with	O
DLBCL	O
sp	O
C1D1	O
DA-EPOCH-R	O
c/b	O
neutropenic	O
fever.	O
He	O
was	O
admitted	O
for	O
C2	O
EPOCH	O
and	O
port	O
exchange.	O
	O
Etoposide	O
100	O
mg	O
IV	O
Days	O
1,	O
2,	O
3	O
and	O
4.	O
___	O
and	O
___	O
(50	O
mg/m2)	O
*Dose	O
before	O
rounding	O
103	O
mg	O
Admix	O
with	O
DOXOrubicin/vinCRIStine	O
if	O
ordered.	O
Infuse	O
each	O
dose	O
over	O
24	O
hours	O
continuous	O
infusion.	O
Total	O
of	O
4	O
doses.	O
	O
DOXOrubicin	O
21	O
mg	O
IV	O
Days	O
1,	O
2,	O
3	O
and	O
4.	O
___	O
and	O
___	O
(10	O
mg/m2)	O
*Dose	O
before	O
rounding	O
20.6	O
mg	O
Admix	O
with	O
Etoposide/vinCRIStine	O
if	O
ordered.	O
Infuse	O
each	O
dose	O
over	O
24	O
hours	O
continuous	O
infusion.	O
Total	O
of	O
4	O
doses.	O
	O
VinCRIStine	O
(Oncovin)	O
0.4	O
mg	O
IV	O
Days	O
1,	O
2,	O
3	O
and	O
4.	O
___	O
and	O
___	O
(0.4	O
mg/m2	O
-	O
dose	O
reduced	O
by	O
50%	O
to	O
0.2	O
mg/m2)	O
Reason	O
for	O
dose	O
reduction:	O
capped	O
at	O
a	O
total	O
dose	O
of	O
2mg	O
*Dose	O
before	O
rounding	O
0.412	O
mg	O
Admix	O
with	O
DOXOrubicin/Etoposide	O
if	O
ordered.	O
Infuse	O
each	O
dose	O
over	O
24	O
hours	O
continuous	O
infusion.	O
Total	O
of	O
4	O
doses.	O
	O
CycloPHOSPHAMIDE	O
1540	O
mg	O
IV	O
Day	O
5.	O
(___)	O
(750	O
mg/m2)	O
*Dose	O
before	O
rounding	O
1545	O
mg	O
Infuse	O
over	O
1	O
hour.	O
Chemotherapy	O
-	O
Supportive	O
Medications	O
	O
PredniSONE	O
120	O
mg	O
PO	O
BID	O
Duration:	O
5	O
Days	O
Start:	O
On	O
Regimen	O
Day	O
1	O
60	O
mg/m2.	O
Access:	O
port	O
with	O
poor	O
blood	O
return	O
despite	O
tPA.	O
Will	O
exchange	O
tomorrow	O
for	O
double	O
lumen	O
port.	O
No	O
DVT	O
ppx	O
until	O
after	O
port	O
exchange.	O
Acute	O
kidney	O
injury:	O
Cr	O
was	O
1.3	O
on	O
admission.	O
Did	O
not	O
improve	O
with	O
IV	O
fluids	O
overnight.	O
Of	O
note	O
presented	O
with	O
renal	O
mass.	O
Of	O
note	O
had	O
been	O
on	O
levaquin	O
for	O
FN	O
after	O
last	O
cycle	O
which	O
could	O
be	O
contributing.	O
Bactrim	O
held	O
during	O
this	O
admission.	O
Creatine	O
improved	O
during	O
stay	O
and	O
Bactrim	O
was	O
restarted	O
at	O
discharge.	O
Continue	O
to	O
follow	O
and	O
trend	O
labs.	O
hypertension:	O
continue	O
home	O
amlodipine.	O
anxiety:	O
continue	O
home	O
escitalopram	O
Medications	O
on	O
Admission:	O
The	O
Preadmission	O
Medication	O
list	O
is	O
accurate	O
and	O
complete.	O
1.	O
Acyclovir	O
400	O
mg	O
PO	O
Q12H	O
2.	O
amLODIPine	O
5	O
mg	O
PO	O
DAILY	O
3.	O
Bisacodyl	O
10	O
mg	O
PO	O
DAILY	O
4.	O
Escitalopram	O
Oxalate	O
10	O
mg	O
PO	O
QHS	O
5.	O
Filgrastim-sndz	O
480	O
mcg	O
SC	O
Q24H	O
6.	O
Omeprazole	O
20	O
mg	O
PO	O
DAILY	O
7.	O
Senna	O
8.6	O
mg	O
PO	O
BID	O
8.	O
Fluticasone	O
Propionate	O
NASAL	O
2	O
SPRY	O
NU	O
BID	O
9.	O
Levofloxacin	O
750	O
mg	O
PO	O
Q24H	O
10.	O
Polyethylene	O
Glycol	O
17	O
g	O
PO	O
DAILY:PRN	O
Constipation	B-Constipation
-	O
Third	O
Line	O
11.	O
Prochlorperazine	O
10	O
mg	O
PO	O
Q6H:PRN	O
nausea	O
and	O
vomiting	O
12.	O
Sulfameth/Trimethoprim	O
SS	O
1	O
TAB	O
PO	O
DAILY	O
Discharge	O
Medications:	O
1.	O
Acyclovir	O
400	O
mg	O
PO	O
Q12H	O
2.	O
amLODIPine	O
5	O
mg	O
PO	O
DAILY	O
3.	O
Bisacodyl	O
10	O
mg	O
PO	O
DAILY	O
4.	O
Escitalopram	O
Oxalate	O
10	O
mg	O
PO	O
QHS	O
5.	O
Filgrastim-sndz	O
480	O
mcg	O
SC	O
Q24H	O
Please	O
start	O
taking	O
___	O
morning.	O
6.	O
Fluticasone	O
Propionate	O
NASAL	O
2	O
SPRY	O
NU	O
BID	O
7.	O
Omeprazole	O
20	O
mg	O
PO	O
DAILY	O
8.	O
Polyethylene	O
Glycol	O
17	O
g	O
PO	O
DAILY:PRN	O
Constipation	B-Constipation
-	O
Third	O
Line	O
9.	O
Prochlorperazine	O
10	O
mg	O
PO	O
Q6H:PRN	O
nausea	O
and	O
vomiting	O
10.	O
Senna	O
8.6	O
mg	O
PO	O
BID	O
11.	O
Sulfameth/Trimethoprim	O
SS	O
1	O
TAB	O
PO	O
DAILY	O
Discharge	O
Disposition:	O
Home	O
Discharge	O
Diagnosis:	O
lymphoma	O
Discharge	O
Condition:	O
Mental	O
Status:	O
Clear	B-Delirium
and	B-Delirium
coherent.	B-Delirium
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Ambulatory	B-Independently_mobile
-	B-Independently_mobile
Independent.	B-Independently_mobile
Discharge	O
Instructions:	O
Dear	O
Mr.	O
___,	O
It	O
was	O
a	O
pleasure	O
taking	O
care	O
of	O
you	O
at	O
___.	O
You	O
were	O
admitted	O
to	O
the	O
hospital	O
for	O
continued	O
chemotherapy	O
to	O
treat	O
your	O
lymphoma.	O
You	O
received	O
your	O
second	O
cycle	O
of	O
EPOCH.	O
Please	O
continue	O
on	O
your	O
medications	O
as	O
listed	O
below.	O
As	O
during	O
your	O
first	O
cycle	O
you	O
will	O
use	O
neupogen,	O
or	O
filgastrim	O
daily	O
and	O
continue	O
taking	O
this	O
medication	O
until	O
being	O
told	O
to	O
stop	O
by	O
your	O
oncologist.	O
Followup	O
Instructions:	O
___	O

